MSR34 Diversity in Clinical Trials: Life Science Initiatives and Challenges in Light of the FDA’s Latest Guidance

Abstract

Authors

M Andrews M Marsh D Walters A King S Daou

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×